Spondylitis ankylopoetica (Bechterew-kór): vizsgálatok itt: Belgium
5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 4. fázisTaking peopleAn open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment
- Where
- Brugge, Genk, Gent, Liège, Mons
- People
- 339 worldwide
- Run by
- Novartis Pharma AG
See details and how to joinNCT04638647 · EU 2023-504417-67-00 - 1. fázisTaking peopleEAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial-1)
- Where
- Gent, Leuven
- Életkor
- 18 év and over
- People
- 86 worldwide
- Run by
- Grey Wolf Therapeutics Limited
See details and how to join2025-521315-39-00 · EU 2025-521315-39-00 - 1/2. fázisTaking peopleEAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)
- Where
- Ghent, Leuven
- Életkor
- 18 év to 65 év
- People
- 140 worldwide
- Run by
- Grey Wolf Therapeutics
See details and how to joinNCT07047703 - 3. fázisTaking peopleOptimizing treatment strategy in axial spondyloarthritis by molecular imaging with Technetium-labeled certolizumab pegol.
- Where
- Gent
- Életkor
- 18 év and over
- People
- 78
- Run by
- Universitair Ziekenhuis Gent
See details and how to join2023-505694-32-00 · EU 2023-505694-32-00 - 4. fázisTaking peopleA Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
- Where
- Leuven, Ghent University Hospital
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- CARE ARTHRITIS LTD.
See details and how to joinNCT06454188 · EU 2023-510242-24-00